Logo

PredictImmune: Steven Martin

Nov 05, 2019

Cambridge, UK-based PredictImmune has appointed Steven Martin to its board. Martin is currently the managing partner of Paxton Advisors, an advisory and consulting firm based in Omaha, Nebraska. He was previously the president and CEO of Blue Cross and Blue Shield of Nebraska, and also belonged to the company's board of directors from 2002 to 2018. Martin was the founding board chair of Think Whole Person Healthcare, a primary care clinic and pharmacy in Nebraska. 

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.